| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transporter activity | ATP5MC3 SLC12A6 GJD2 SLC17A3 SLC35D2 SLC10A4 SLC19A2 ATP10B TMC4 SLCO6A1 ABCA9 SLC35D1 SLC6A1 ATP6V0D1 PKD2L2 SLC22A16 SLC15A2 SV2B SLC15A4 SLC22A13 SLC10A5 SCN5A SCN8A SCN9A LRP2 TRPV4 ATP13A3 SLC45A1 RFT1 SLC33A1 | 2.08e-08 | 1289 | 149 | 30 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ATP5MC3 SLC12A6 GJD2 SLC17A3 SLC35D2 SLC10A4 SLC19A2 TMC4 SLCO6A1 ABCA9 SLC35D1 SLC6A1 ATP6V0D1 PKD2L2 SLC22A16 SLC15A2 SV2B SLC15A4 SLC22A13 SLC10A5 SCN5A SCN8A SCN9A TRPV4 ATP13A3 SLC45A1 SLC33A1 | 1.69e-07 | 1180 | 149 | 27 | GO:0022857 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC12A6 SLC17A3 SLC10A4 SLC6A1 SLC15A2 SLC15A4 SLC10A5 SLC45A1 | 3.10e-06 | 119 | 149 | 8 | GO:0015294 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC17A3 SLC35D2 SLC10A4 SLC19A2 SLCO6A1 SLC35D1 SLC6A1 SLC15A4 SLC22A13 SLC10A5 SLC33A1 | 1.29e-05 | 293 | 149 | 11 | GO:0008514 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC12A6 SLC17A3 SLC35D2 SLC10A4 SLCO6A1 ABCA9 SLC35D1 SLC6A1 ATP6V0D1 SLC15A2 SLC15A4 SLC10A5 ATP13A3 SLC45A1 | 1.40e-05 | 477 | 149 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC12A6 SLC17A3 SLC35D2 SLC10A4 SLCO6A1 SLC35D1 SLC6A1 SLC15A2 SLC15A4 SLC10A5 SLC45A1 | 1.42e-05 | 296 | 149 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | symporter activity | SLC12A6 SLC17A3 SLC10A4 SLC6A1 SLC15A2 SLC15A4 SLC10A5 SLC45A1 | 1.71e-05 | 150 | 149 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ATP5MC3 SLC12A6 SLC17A3 SLC10A4 SLC6A1 ATP6V0D1 PKD2L2 SLC15A2 SLC15A4 SLC10A5 SCN5A SCN8A SCN9A TRPV4 ATP13A3 SLC45A1 | 3.78e-05 | 664 | 149 | 16 | GO:0008324 |
| GeneOntologyMolecularFunction | UDP-glucuronic acid transmembrane transporter activity | 5.53e-05 | 2 | 149 | 2 | GO:0005461 | |
| GeneOntologyMolecularFunction | UDP-N-acetylgalactosamine transmembrane transporter activity | 5.53e-05 | 2 | 149 | 2 | GO:0005463 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ATP5MC3 SLC12A6 SLC17A3 SLC10A4 SLC6A1 ATP6V0D1 PKD2L2 SLC15A2 SLC15A4 SLC10A5 SCN5A SCN8A SCN9A TRPV4 SLC45A1 | 7.24e-05 | 627 | 149 | 15 | GO:0022890 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC12A6 SLC17A3 SLC10A4 SLC6A1 ATP6V0D1 SLC15A2 SLC15A4 SLC10A5 ATP13A3 SLC45A1 | 9.01e-05 | 301 | 149 | 10 | GO:0022853 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | ATP5MC3 SLC12A6 SLC17A3 SLC10A4 TMC4 SLC6A1 ATP6V0D1 PKD2L2 SLC15A2 SLC15A4 SLC10A5 SCN5A SCN8A SCN9A TRPV4 ATP13A3 SLC45A1 | 9.10e-05 | 793 | 149 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | protein serine/threonine phosphatase activity | 1.68e-04 | 109 | 149 | 6 | GO:0004722 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 1.73e-04 | 15 | 149 | 3 | GO:0140161 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 2.67e-04 | 42 | 149 | 4 | GO:0042887 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.02e-04 | 171 | 149 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | peptide:proton symporter activity | 3.29e-04 | 4 | 149 | 2 | GO:0015333 | |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 3.61e-04 | 19 | 149 | 3 | GO:0015355 | |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 4.39e-04 | 85 | 149 | 5 | GO:0017018 | |
| GeneOntologyMolecularFunction | calcium ion binding | CRACR2A PCDHGB1 CDHR1 FAT3 ADGRV1 FAT2 PKD2L2 GUCA1A ANKEF1 RHBDL3 LRP2 NECAB3 SYT5 PLCG1 EFCAB7 | 4.93e-04 | 749 | 149 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | UDP-N-acetylglucosamine transmembrane transporter activity | 5.45e-04 | 5 | 149 | 2 | GO:0005462 | |
| GeneOntologyMolecularFunction | dipeptide transmembrane transporter activity | 5.45e-04 | 5 | 149 | 2 | GO:0071916 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 5.52e-04 | 189 | 149 | 7 | GO:0004721 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ATP5MC3 SLC12A6 SLC17A3 SLC10A4 SLC6A1 ATP6V0D1 PKD2L2 SLC15A2 SLC15A4 SLC10A5 SCN5A SCN8A SCN9A TRPV4 SLC45A1 | 5.57e-04 | 758 | 149 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | phosphoric ester hydrolase activity | CPPED1 PLCXD1 ACP5 DUSP8 LRRIQ4 MDP1 PPP5C DUSP16 PHLPP1 PLCG1 | 6.55e-04 | 386 | 149 | 10 | GO:0042578 |
| GeneOntologyMolecularFunction | bile acid:sodium symporter activity | 8.13e-04 | 6 | 149 | 2 | GO:0008508 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 8.30e-04 | 25 | 149 | 3 | GO:0015295 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 9.33e-04 | 26 | 149 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 9.85e-04 | 59 | 149 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | phosphatase activity | 1.43e-03 | 287 | 149 | 8 | GO:0016791 | |
| GeneOntologyMolecularFunction | urate transmembrane transporter activity | 1.92e-03 | 9 | 149 | 2 | GO:0015143 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 1.92e-03 | 9 | 149 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | salt transmembrane transporter activity | 1.92e-03 | 9 | 149 | 2 | GO:1901702 | |
| GeneOntologyMolecularFunction | acid phosphatase activity | 1.92e-03 | 9 | 149 | 2 | GO:0003993 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 2.24e-03 | 35 | 149 | 3 | GO:0005343 | |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 2.39e-03 | 10 | 149 | 2 | GO:0140031 | |
| GeneOntologyMolecularFunction | MAP kinase tyrosine phosphatase activity | 2.39e-03 | 10 | 149 | 2 | GO:0033550 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.43e-03 | 36 | 149 | 3 | GO:0019789 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC12A6 SLC17A3 SLC10A4 SLC6A1 PKD2L2 SLC10A5 SCN5A SCN8A SCN9A TRPV4 | 2.62e-03 | 465 | 149 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | polyamine transmembrane transporter activity | 2.91e-03 | 11 | 149 | 2 | GO:0015203 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 2.91e-03 | 11 | 149 | 2 | GO:0015165 | |
| GeneOntologyMolecularFunction | protein tyrosine/threonine phosphatase activity | 2.91e-03 | 11 | 149 | 2 | GO:0008330 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 2.91e-03 | 11 | 149 | 2 | GO:0180030 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 3.17e-03 | 81 | 149 | 4 | GO:0015370 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.47e-03 | 83 | 149 | 4 | GO:0015101 | |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 4.04e-03 | 43 | 149 | 3 | GO:0001965 | |
| GeneOntologyMolecularFunction | MAP kinase tyrosine/serine/threonine phosphatase activity | 4.09e-03 | 13 | 149 | 2 | GO:0017017 | |
| GeneOntologyBiologicalProcess | maintenance of animal organ identity | 3.73e-06 | 5 | 150 | 3 | GO:0048496 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative transport | 6.49e-06 | 96 | 150 | 7 | GO:1901264 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | ATP5MC3 SLC12A6 CXCR3 CRACR2A SLC17A3 SLC10A4 TMC4 SLC6A1 ATP6V0D1 PKD2L2 SLC22A16 SLC15A2 MTOR SLC15A4 SLC10A5 GNB5 SCN5A SCN8A SCN9A LRP2 PKP2 TRPV4 ATP13A3 PLCG1 PML | 1.90e-05 | 1374 | 150 | 25 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | ATP5MC3 SLC12A6 CXCR3 CRACR2A SLC17A3 SLC10A4 SLC6A1 ATP6V0D1 PKD2L2 SLC15A2 SLC15A4 SLC10A5 GNB5 SCN5A SCN8A SCN9A LRP2 PKP2 TRPV4 ATP13A3 PLCG1 PML | 3.32e-05 | 1157 | 150 | 22 | GO:0006812 |
| GeneOntologyBiologicalProcess | UDP-N-acetylgalactosamine transmembrane transport | 5.25e-05 | 2 | 150 | 2 | GO:0015789 | |
| GeneOntologyBiologicalProcess | UDP-glucuronic acid transmembrane transport | 5.25e-05 | 2 | 150 | 2 | GO:0015787 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 9.52e-05 | 63 | 150 | 5 | GO:0019228 | |
| GeneOntologyBiologicalProcess | peptidoglycan transport | 1.57e-04 | 3 | 150 | 2 | GO:0015835 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 1.70e-04 | 112 | 150 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | ATP5MC3 SLC12A6 CXCR3 CRACR2A SLC17A3 TMC4 SLC6A1 ATP6V0D1 PKD2L2 SLC15A2 MTOR SLC15A4 GNB5 SCN5A SCN8A SCN9A TRPV4 ATP13A3 PLCG1 PML | 1.72e-04 | 1115 | 150 | 20 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ATP5MC3 SLC12A6 CXCR3 CRACR2A SLC17A3 SLC6A1 ATP6V0D1 PKD2L2 SLC15A2 SLC15A4 GNB5 SCN5A SCN8A SCN9A TRPV4 ATP13A3 PLCG1 PML | 1.73e-04 | 942 | 150 | 18 | GO:0098655 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.36e-04 | 157 | 149 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.24e-04 | 17 | 149 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | USH2 complex | 3.00e-04 | 4 | 149 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | piP-body | 4.98e-04 | 5 | 149 | 2 | GO:0071547 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 6.08e-04 | 201 | 149 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 7.43e-04 | 6 | 149 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 7.43e-04 | 6 | 149 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 7.43e-04 | 6 | 149 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 7.43e-04 | 6 | 149 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | glutamatergic synapse | DLG5 CNTNAP1 ITGA8 LRRC4B LRRC4C SLITRK1 ITPKA SV2B MTOR ELFN1 SCN8A ANP32E ELAVL1 LPAR2 PLCG1 | 7.53e-04 | 817 | 149 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | apical part of cell | SLC12A6 MGAM SLC17A3 ITGA8 ATP6V0D1 FRMD6 SLC15A2 SLC22A13 LRP2 GPSM2 TRPV4 USH2A | 1.12e-03 | 592 | 149 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | sodium channel complex | 1.13e-03 | 29 | 149 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.37e-03 | 8 | 149 | 2 | GO:0002139 | |
| Domain | MFS_dom | SLC17A3 SLC19A2 SLCO6A1 SLC22A16 SLC15A2 SV2B SLC15A4 SLC22A13 SLC33A1 | 1.36e-06 | 134 | 150 | 9 | IPR020846 |
| Domain | TPR_REGION | 7.54e-06 | 165 | 150 | 9 | PS50293 | |
| Domain | TPR | 7.54e-06 | 165 | 150 | 9 | PS50005 | |
| Domain | Na_trans_cytopl | 9.98e-06 | 6 | 150 | 3 | PF11933 | |
| Domain | Na_trans_cytopl | 9.98e-06 | 6 | 150 | 3 | IPR024583 | |
| Domain | TPR-like_helical_dom | 1.92e-05 | 233 | 150 | 10 | IPR011990 | |
| Domain | TPR-contain_dom | 2.88e-05 | 150 | 150 | 8 | IPR013026 | |
| Domain | LRR | 3.63e-05 | 201 | 150 | 9 | PS51450 | |
| Domain | Na_channel_asu | 5.85e-05 | 10 | 150 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 5.85e-05 | 10 | 150 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 5.85e-05 | 10 | 150 | 3 | PF06512 | |
| Domain | Compl_C2_B | 6.41e-05 | 2 | 150 | 2 | IPR011360 | |
| Domain | LRR_TYP | 9.31e-05 | 177 | 150 | 8 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 9.31e-05 | 177 | 150 | 8 | IPR003591 | |
| Domain | - | 1.17e-04 | 95 | 150 | 6 | 2.60.120.200 | |
| Domain | PTR2_symporter_CS | 1.91e-04 | 3 | 150 | 2 | IPR018456 | |
| Domain | LAM_G_DOMAIN | 2.39e-04 | 38 | 150 | 4 | PS50025 | |
| Domain | - | 2.73e-04 | 207 | 150 | 8 | 1.25.40.10 | |
| Domain | Laminin_G_2 | 2.92e-04 | 40 | 150 | 4 | PF02210 | |
| Domain | Leu-rich_rpt | 3.49e-04 | 271 | 150 | 9 | IPR001611 | |
| Domain | PTR2_2 | 3.80e-04 | 4 | 150 | 2 | PS01023 | |
| Domain | LRR_1 | 3.98e-04 | 219 | 150 | 8 | PF00560 | |
| Domain | LamG | 4.23e-04 | 44 | 150 | 4 | SM00282 | |
| Domain | LRR_8 | 4.68e-04 | 171 | 150 | 7 | PF13855 | |
| Domain | IQ | 4.90e-04 | 81 | 150 | 5 | SM00015 | |
| Domain | EF-hand-dom_pair | CRACR2A GUCA1A ANKEF1 RHBDL3 SCN8A SCN9A NECAB3 PLCG1 EFCAB7 | 5.29e-04 | 287 | 150 | 9 | IPR011992 |
| Domain | TPR | 6.14e-04 | 129 | 150 | 6 | SM00028 | |
| Domain | POT_fam | 6.31e-04 | 5 | 150 | 2 | IPR000109 | |
| Domain | PTR2 | 6.31e-04 | 5 | 150 | 2 | PF00854 | |
| Domain | TPR_1 | 7.94e-04 | 90 | 150 | 5 | IPR001440 | |
| Domain | Cys-rich_flank_reg_C | 7.94e-04 | 90 | 150 | 5 | IPR000483 | |
| Domain | TPR_1 | 7.94e-04 | 90 | 150 | 5 | PF00515 | |
| Domain | LRRCT | 7.94e-04 | 90 | 150 | 5 | SM00082 | |
| Domain | IQ_motif_EF-hand-BS | 7.94e-04 | 90 | 150 | 5 | IPR000048 | |
| Domain | IQ | 9.21e-04 | 93 | 150 | 5 | PS50096 | |
| Domain | FAT | 9.41e-04 | 6 | 150 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 9.41e-04 | 6 | 150 | 2 | IPR003151 | |
| Domain | - | 1.17e-03 | 321 | 150 | 9 | 3.80.10.10 | |
| Domain | Laminin_G | 1.21e-03 | 58 | 150 | 4 | IPR001791 | |
| Domain | SBF | 1.31e-03 | 7 | 150 | 2 | PF01758 | |
| Domain | BilAc:Na_symport/Acr3 | 1.31e-03 | 7 | 150 | 2 | IPR002657 | |
| Domain | IPK | 1.31e-03 | 7 | 150 | 2 | PF03770 | |
| Domain | IPK | 1.31e-03 | 7 | 150 | 2 | IPR005522 | |
| Domain | L_dom-like | 1.36e-03 | 328 | 150 | 9 | IPR032675 | |
| Domain | Metallophos | 1.44e-03 | 28 | 150 | 3 | PF00149 | |
| Domain | Calcineurin-like_PHP_ApaH | 1.44e-03 | 28 | 150 | 3 | IPR004843 | |
| Domain | ARM-type_fold | 1.70e-03 | 339 | 150 | 9 | IPR016024 | |
| Domain | Metallo-depent_PP-like | 1.76e-03 | 30 | 150 | 3 | IPR029052 | |
| Domain | - | 1.76e-03 | 30 | 150 | 3 | 3.60.21.10 | |
| Domain | ConA-like_dom | 1.98e-03 | 219 | 150 | 7 | IPR013320 | |
| Domain | EF_HAND_2 | 2.67e-03 | 231 | 150 | 7 | PS50222 | |
| Domain | EF_hand_dom | 2.73e-03 | 232 | 150 | 7 | IPR002048 | |
| Domain | Leu-rich_rpt_4 | 2.76e-03 | 10 | 150 | 2 | IPR025875 | |
| Domain | Sugar_P_trans_dom | 2.76e-03 | 10 | 150 | 2 | IPR004853 | |
| Domain | MKP | 2.76e-03 | 10 | 150 | 2 | IPR008343 | |
| Domain | LRR_4 | 2.76e-03 | 10 | 150 | 2 | PF12799 | |
| Domain | TPT | 2.76e-03 | 10 | 150 | 2 | PF03151 | |
| Domain | MFS_sugar_transport-like | 2.99e-03 | 36 | 150 | 3 | IPR005828 | |
| Domain | Sugar_tr | 2.99e-03 | 36 | 150 | 3 | PF00083 | |
| Domain | MFS_1 | 3.43e-03 | 77 | 150 | 4 | PF07690 | |
| Domain | MFS | 3.43e-03 | 77 | 150 | 4 | IPR011701 | |
| Domain | TPR_repeat | 4.41e-03 | 133 | 150 | 5 | IPR019734 | |
| Domain | EF-hand_7 | 4.89e-03 | 85 | 150 | 4 | PF13499 | |
| Domain | - | 5.20e-03 | 261 | 150 | 7 | 1.10.238.10 | |
| Domain | TUDOR | 5.47e-03 | 14 | 150 | 2 | PF00567 | |
| Pubmed | Early development of electrical excitability in the mouse enteric nervous system. | 8.13e-07 | 5 | 152 | 3 | 22875929 | |
| Pubmed | 2.38e-06 | 87 | 152 | 6 | 20801516 | ||
| Pubmed | 2.83e-06 | 7 | 152 | 3 | 27553280 | ||
| Pubmed | 6.74e-06 | 9 | 152 | 3 | 16382098 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 22232432 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 3315100 | ||
| Pubmed | PML colocalizes with and stabilizes the DNA damage response protein TopBP1. | 1.90e-05 | 2 | 152 | 2 | 12773567 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 9430715 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 24618665 | ||
| Pubmed | HuR-mediated SCN5A messenger RNA stability reduces arrhythmic risk in heart failure. | 1.90e-05 | 2 | 152 | 2 | 29454929 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 24965207 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 22474331 | ||
| Pubmed | mTOR-dependent regulation of PHLPP expression controls the rapamycin sensitivity in cancer cells. | 1.90e-05 | 2 | 152 | 2 | 21177869 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 31166939 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 1970336 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 2229060 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 19696172 | ||
| Pubmed | SCP phosphatases suppress renal cell carcinoma by stabilizing PML and inhibiting mTOR/HIF signaling. | 1.90e-05 | 2 | 152 | 2 | 25293974 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 17576744 | ||
| Pubmed | Sodium channel slow inactivation interferes with open channel block. | 1.90e-05 | 2 | 152 | 2 | 27174182 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 15671307 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 34638692 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 17482263 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 22869612 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 29784761 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 26861708 | ||
| Pubmed | Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation. | 1.90e-05 | 2 | 152 | 2 | 28653555 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 24548120 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 7641699 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 18806293 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 34647573 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 35541896 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 16518403 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 3643061 | ||
| Pubmed | PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies. | 1.90e-05 | 2 | 152 | 2 | 23440206 | |
| Pubmed | 2.27e-05 | 13 | 152 | 3 | 15123669 | ||
| Pubmed | 2.88e-05 | 14 | 152 | 3 | 19244508 | ||
| Pubmed | Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | 2.88e-05 | 14 | 152 | 3 | 28878358 | |
| Pubmed | PML nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4. | 5.68e-05 | 3 | 152 | 2 | 28332630 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 26362587 | ||
| Pubmed | The Role of Deoxycytidine Kinase (dCK) in Radiation-Induced Cell Death. | 5.68e-05 | 3 | 152 | 2 | 27879648 | |
| Pubmed | Complement C4bC2 complex formation: an investigation by surface plasmon resonance. | 5.68e-05 | 3 | 152 | 2 | 11341920 | |
| Pubmed | PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome. | 5.68e-05 | 3 | 152 | 2 | 20440071 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 21502587 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 24519512 | ||
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 5.68e-05 | 3 | 152 | 2 | 15744052 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 38117454 | ||
| Pubmed | CENP-C and CENP-I are key connecting factors for kinetochore and CENP-A assembly. | 5.68e-05 | 3 | 152 | 2 | 26527398 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 11956228 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 25677447 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 24990947 | ||
| Pubmed | Expression profile and functional activity of peptide transporters in prostate cancer cells. | 5.68e-05 | 3 | 152 | 2 | 22950754 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 23444213 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 17419608 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 22147658 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 19881535 | ||
| Pubmed | Accelerated nephrotoxic nephritis is exacerbated in C1q-deficient mice. | 5.68e-05 | 3 | 152 | 2 | 11359841 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 28761320 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 15218033 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 10229798 | ||
| Pubmed | Pml represses tumour progression through inhibition of mTOR. | 5.68e-05 | 3 | 152 | 2 | 21387562 | |
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 20038812 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 29678826 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 20065024 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 29142287 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 22273503 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 16434480 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 31073693 | ||
| Pubmed | 5.68e-05 | 3 | 152 | 2 | 15302875 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 7.14e-05 | 497 | 152 | 10 | 36774506 | |
| Pubmed | 9.93e-05 | 418 | 152 | 9 | 34709266 | ||
| Pubmed | 1.01e-04 | 105 | 152 | 5 | 9628581 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 23233260 | ||
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 1.13e-04 | 4 | 152 | 2 | 18463160 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 20502675 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 18490760 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 30179527 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 20301515 | ||
| Pubmed | Reduced AMPK-ACC and mTOR signaling in muscle from older men, and effect of resistance exercise. | 1.13e-04 | 4 | 152 | 2 | 23000302 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 27486771 | ||
| Pubmed | The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. | 1.13e-04 | 4 | 152 | 2 | 12905028 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 6088393 | ||
| Pubmed | PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling. | 1.13e-04 | 4 | 152 | 2 | 34031390 | |
| Pubmed | Divergent outer retinal circuits drive image and non-image visual behaviors. | 1.13e-04 | 4 | 152 | 2 | 35767957 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 18541650 | ||
| Pubmed | C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes. | 1.13e-04 | 4 | 152 | 2 | 18493315 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 19399715 | ||
| Pubmed | Adenylyl cyclase 6 plays a minor role in the mouse inner ear and retina. | 1.13e-04 | 4 | 152 | 2 | 37127773 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 26401052 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 37066759 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 18806297 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 21366347 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 23115237 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 23055499 | ||
| Pubmed | PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR. | 1.13e-04 | 4 | 152 | 2 | 16915281 | |
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 19556007 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 17631500 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 25406310 | ||
| Pubmed | 1.13e-04 | 4 | 152 | 2 | 9891995 | ||
| Pubmed | Orientation and molecular map position of the complement genes in the mouse MHC. | 1.13e-04 | 4 | 152 | 2 | 3034587 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q14 | 5.20e-05 | 61 | 152 | 4 | chr15q14 | |
| GeneFamily | Solute carriers | SLC12A6 SLC17A3 SLC35D2 SLC10A4 SLC19A2 SLCO6A1 SLC35D1 SLC6A1 SLC22A16 SLC15A2 SLC15A4 SLC22A13 SLC10A5 SLC45A1 SLC33A1 | 2.44e-08 | 395 | 113 | 15 | 752 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.94e-05 | 9 | 113 | 3 | 1203 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.44e-05 | 115 | 113 | 6 | 769 | |
| GeneFamily | Cadherin related | 1.52e-04 | 17 | 113 | 3 | 24 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 2.30e-04 | 4 | 113 | 2 | 1244 | |
| GeneFamily | EF-hand domain containing | 4.53e-04 | 219 | 113 | 7 | 863 | |
| GeneFamily | Tudor domain containing | 1.58e-03 | 37 | 113 | 3 | 780 | |
| GeneFamily | MAP kinase phosphatases | 2.05e-03 | 11 | 113 | 2 | 895 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-07 | 184 | 152 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-07 | 184 | 152 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-07 | 184 | 152 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.57e-07 | 194 | 152 | 8 | 46e522ca59db545d1eb0c27cd4361f19d4f8f762 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 4.49e-07 | 200 | 152 | 8 | fe772d98c461c973dfc082e1fc50117c27ced804 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 168 | 152 | 7 | b14fd50232887b6dca1f39014d43c6f66e5c3b5c | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-06 | 169 | 152 | 7 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 169 | 152 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 175 | 152 | 7 | 076ad81d6cbeea5512393d192af3ab5aa1f82975 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 175 | 152 | 7 | 445ccb9744a3a9ff37164c532afbe769d306b6c8 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.12e-06 | 182 | 152 | 7 | 21dcab170ffeef89faa9fee5008568cb6e15c694 | |
| ToppCell | COPD-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 4.28e-06 | 191 | 152 | 7 | 3ae18bc4e3dff49b5d5958da8ebc3f747274b69c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.43e-06 | 192 | 152 | 7 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.25e-06 | 197 | 152 | 7 | c0250509836f1be04f5e54386191d7bb1e1da652 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 197 | 152 | 7 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 5.42e-06 | 198 | 152 | 7 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | Sepsis-Leuk-UTI-Myeloid-pDC|Leuk-UTI / Disease, condition lineage and cell class | 5.61e-06 | 199 | 152 | 7 | 2f8d297afd26ae1e9fb66d8573274452c4133b6c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.79e-06 | 200 | 152 | 7 | 8827653738a931e4a4545e0c7d75be12bed40740 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 148 | 152 | 6 | f85dc34f6a4a15ecffa4fbd5644dea12ce30089b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 148 | 152 | 6 | 4b1fdf90c585f89cee1cf521db4e3fafc9d74d9a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 148 | 152 | 6 | 55826b7e9f79ab78a93abd4fc662bc37aa121471 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 160 | 152 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.86e-05 | 160 | 152 | 6 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.86e-05 | 160 | 152 | 6 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 160 | 152 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 165 | 152 | 6 | 082f62f759a0b16ab56fad6dd4c4dd70b4f18a5c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 166 | 152 | 6 | 8ab18c9d911eb3a9970bba7a769294b0927538f7 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 166 | 152 | 6 | 0868f45d8d39ad39b5cee5e81ac3dd4dc512775d | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 167 | 152 | 6 | ed7e785dcd25777f64e0c2596ada4f5a5ea17121 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-05 | 168 | 152 | 6 | dd48da83c32d41a62f80cd7e5e5c64e42776fa27 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-05 | 169 | 152 | 6 | f00741203efa0b948db7223ee8c19bdd0918258a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.53e-05 | 169 | 152 | 6 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.62e-05 | 170 | 152 | 6 | badbe200e9d5003d23d115955b10b4ea767f6c26 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.62e-05 | 170 | 152 | 6 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-05 | 170 | 152 | 6 | dd48fd3c5c67eb71183981f42975a538f12077c3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.71e-05 | 171 | 152 | 6 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 171 | 152 | 6 | 48fc4eca18b102b5ec5050f758281292ee8e10c6 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-05 | 171 | 152 | 6 | 05fcc72df50a380a913821b5781d9621df37d328 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.71e-05 | 171 | 152 | 6 | 1f8e66073088fc1969782e443bf00f8c1877ea91 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 173 | 152 | 6 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-05 | 173 | 152 | 6 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.08e-05 | 175 | 152 | 6 | 13843bfc8efe7c01f19ebb6735609c1eec09c698 | |
| ToppCell | facs-BAT-Fat-3m-Epithelial|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 177 | 152 | 6 | 3e42f6236962dd9bb23dc0d09b460ec8347d1056 | |
| ToppCell | facs-BAT-Fat-3m-Epithelial-epithelial_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 177 | 152 | 6 | 128186bc996784e670194c07c5352e69af5f6d68 | |
| ToppCell | Mild/Remission-B_memory-6|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.28e-05 | 177 | 152 | 6 | 8f2ce5ffc94ca90412cb6899629f322dc778215c | |
| ToppCell | facs-BAT-Fat-3m-Epithelial-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-05 | 177 | 152 | 6 | 7480e522cfae3f5c6c62720083750f8273725ab5 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.50e-05 | 179 | 152 | 6 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, Lineage and Cell Type | 3.61e-05 | 180 | 152 | 6 | be665e801512f6aaf6b3ecb26153bbdeb24619ac | |
| ToppCell | Control-Lymphoid-T_Regulatory|World / Disease state, Lineage and Cell class | 3.61e-05 | 180 | 152 | 6 | 47036eee4c128fbb443d1fc767b4de5cced93f0e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.72e-05 | 181 | 152 | 6 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.72e-05 | 181 | 152 | 6 | 153709b4dd3d81e09f251fa8765b58bed1932fda | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 3.84e-05 | 182 | 152 | 6 | 02e04294fce12591c32d7bd0e866a000ad1f836e | |
| ToppCell | Control-Lymphoid-T_Regulatory|Control / Disease state, Lineage and Cell class | 3.84e-05 | 182 | 152 | 6 | 31bb838cc2900f3c9da9f835d79d557a08abb928 | |
| ToppCell | (7)_DC_plasmacytoid|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.95e-05 | 183 | 152 | 6 | 2c6475c935b5a90931be6b3c53f1f707cfcd11f4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.08e-05 | 184 | 152 | 6 | 6475a43201b136dcc9b113d2ca4cfa154ed9d65d | |
| ToppCell | Control-Lymphoid-T_Regulatory|Lymphoid / Disease state, Lineage and Cell class | 4.20e-05 | 185 | 152 | 6 | e481cacda0b6b25f5f0062b962df9a442053ac30 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.60e-05 | 188 | 152 | 6 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-05 | 188 | 152 | 6 | c2c51c6526defe2600302901159b8abbb58d7595 | |
| ToppCell | myeloid-pDC|myeloid / Lineage and Cell class | 4.60e-05 | 188 | 152 | 6 | a2dc4bbeca2bdc00c51825dd65a699c54c72f241 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.87e-05 | 190 | 152 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-erythroid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.87e-05 | 190 | 152 | 6 | cf463b2f227f3cc7d3fd296c810c0cbe51cbee72 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.02e-05 | 191 | 152 | 6 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | Control-Myeloid-pDC|Control / Disease, Lineage and Cell Type | 5.02e-05 | 191 | 152 | 6 | 473f904fe244d919ce561139591a2be12cc9fa6b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.17e-05 | 192 | 152 | 6 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.17e-05 | 192 | 152 | 6 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.17e-05 | 192 | 152 | 6 | 8898332387e5d746feb346ce1dabd6b2218fc6e5 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.47e-05 | 194 | 152 | 6 | 784b15119c91ace33d34bfb3d68c182566a3e9a8 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.63e-05 | 195 | 152 | 6 | b67d4f34cae729c18275486d3b20c9dd7d5cbe79 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.79e-05 | 196 | 152 | 6 | 97324c9e93f833e1f218e81fb53066d44c6892df | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Suprabasal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.13e-05 | 198 | 152 | 6 | 28ada093cec552262731194a04a4b9ff93186c3b | |
| ToppCell | (5)_Dendritic_cell-(54)_pDC|(5)_Dendritic_cell / shred on Cell_type and subtype | 6.13e-05 | 198 | 152 | 6 | fc6c6b60dddd7f2f997af0f87fae33f1c23f34a8 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 6.13e-05 | 198 | 152 | 6 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.13e-05 | 198 | 152 | 6 | cbb63b255bdc92a557c5db1f08f7766ed9346607 | |
| ToppCell | Sepsis-Leuk-UTI-Others|Leuk-UTI / Disease, condition lineage and cell class | 6.30e-05 | 199 | 152 | 6 | e45fe91f1d1c47a305b0f39d808730723852af00 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, condition lineage and cell class | 6.30e-05 | 199 | 152 | 6 | 90ddd686b8f39c6f6134b9b048396cebcf8d0448 | |
| ToppCell | MS-IIF-Myeloid-pDC|IIF / Disease, condition lineage and cell class | 6.30e-05 | 199 | 152 | 6 | e262ee854e64d87460bee810c14d6cbe744460e8 | |
| ToppCell | Sepsis-Leuk-UTI-Others-RBC|Leuk-UTI / Disease, condition lineage and cell class | 6.30e-05 | 199 | 152 | 6 | d9b517199a646c9461c615412ad5b58cf4bed7c8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.30e-05 | 199 | 152 | 6 | f4fdf94c561dca35bb17766d908c5030655f43eb | |
| ToppCell | Control-Control-Myeloid-pDC|Control / Disease, condition lineage and cell class | 6.30e-05 | 199 | 152 | 6 | 8e9cac53fabe497ffa27fca0627eafe883af2534 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class | 6.30e-05 | 199 | 152 | 6 | 9de61e5189d907cc969ac3043d68204f70acc0bf | |
| ToppCell | 356C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 6.30e-05 | 199 | 152 | 6 | c0fe99ed906d0eb99cccdab9a1fa32c17b3542e7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.48e-05 | 200 | 152 | 6 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.48e-05 | 200 | 152 | 6 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.48e-05 | 200 | 152 | 6 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.48e-05 | 200 | 152 | 6 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.48e-05 | 200 | 152 | 6 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.48e-05 | 200 | 152 | 6 | 913487e065dd580c9cbcbb3c3fc76a8d446f8856 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.48e-05 | 200 | 152 | 6 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.48e-05 | 200 | 152 | 6 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | (54)_pDC|World / shred on Cell_type and subtype | 7.03e-05 | 203 | 152 | 6 | b8ba3e51770ff7b45cd02472f3e63aa4d5816f6f | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 139 | 152 | 5 | 82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 139 | 152 | 5 | fc9ac09c2106e88104a52575832d71d17765eec8 | |
| ToppCell | facs-Liver-Hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 139 | 152 | 5 | fc4b39ac9a10cf0acacfebbc4295edf324d930d5 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 139 | 152 | 5 | 4ddfbc36a0560fb70594627178bff652ab1ea3e9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-04 | 143 | 152 | 5 | 8f897278f9ccc82ae35e4f30c5f930b2a3eb509d | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 143 | 152 | 5 | d877d914e4e74db2053baa310d318d6440e672bc | |
| ToppCell | frontal_cortex-Non-neuronal-macrophage-Macrophage-PVM_Mrc1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.54e-04 | 148 | 152 | 5 | d3ea907f8f408e9bb97ed223a3089e403e35f911 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 150 | 152 | 5 | d44c02402e59a45e40b8fffbe71284032b5e7c92 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 150 | 152 | 5 | e020dbcf85c0ba7ad667b8bbeb6bbcfc135c9bb7 | |
| ToppCell | Substantia_nigra-Hematopoietic-MICROGLIA-MI2(C1qb)-MICROGLIA_Microglia.C1qb.Tmem119_(Microglia.C1qb.Tmem119)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 150 | 152 | 5 | edbc1d29d213bf5908592135700e0d80e123c923 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.45e-05 | 10 | 148 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.45e-05 | 10 | 148 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | MACULAR DEGENERATION, AGE-RELATED, 14 | 2.50e-05 | 2 | 148 | 2 | C3809653 | |
| Disease | Age related macular degeneration 14 | 2.50e-05 | 2 | 148 | 2 | cv:C3809653 | |
| Disease | age related macular degeneration 14 (is_implicated_in) | 2.50e-05 | 2 | 148 | 2 | DOID:0110026 (is_implicated_in) | |
| Disease | MACULAR DEGENERATION, AGE-RELATED, 14 | 2.50e-05 | 2 | 148 | 2 | 615489 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.63e-05 | 12 | 148 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | B Virus Infection | 7.47e-05 | 3 | 148 | 2 | C0037140 | |
| Disease | Postherpetic neuralgia | 7.47e-05 | 3 | 148 | 2 | C0032768 | |
| Disease | Herpesviridae Infections | 7.47e-05 | 3 | 148 | 2 | C0019372 | |
| Disease | Arrhythmogenic Right Ventricular Dysplasia | 7.47e-05 | 3 | 148 | 2 | C0349788 | |
| Disease | alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase measurement | 2.47e-04 | 5 | 148 | 2 | EFO_0801370 | |
| Disease | revision of total knee arthroplasty | 2.95e-04 | 26 | 148 | 3 | EFO_0020972 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 4.55e-04 | 71 | 148 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | ER membrane protein complex subunit 4 measurement | 5.16e-04 | 7 | 148 | 2 | EFO_0801580 | |
| Disease | Spondylometaphyseal dysplasia | 5.16e-04 | 7 | 148 | 2 | cv:C4759767 | |
| Disease | Type II Collagenopathies | 5.16e-04 | 7 | 148 | 2 | cv:CN043672 | |
| Disease | muscular atrophy (implicated_via_orthology) | 5.16e-04 | 7 | 148 | 2 | DOID:767 (implicated_via_orthology) | |
| Disease | lifestyle measurement, anxiety disorder measurement | 6.52e-04 | 137 | 148 | 5 | EFO_0007795, EFO_0010724 | |
| Disease | response to vitamin | 6.86e-04 | 8 | 148 | 2 | GO_0033273 | |
| Disease | retinal detachment, retinal break | 7.19e-04 | 35 | 148 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | complement factor B measurement | 8.79e-04 | 9 | 148 | 2 | EFO_0008096 | |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 8.79e-04 | 9 | 148 | 2 | C3502809 | |
| Disease | periodontitis | 9.41e-04 | 223 | 148 | 6 | EFO_0000649 | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.15e-03 | 41 | 148 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | Jeune thoracic dystrophy | 1.33e-03 | 11 | 148 | 2 | C0265275 | |
| Disease | quality of life during menstruation measurement, acne | 1.33e-03 | 11 | 148 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | Myoclonic Astatic Epilepsy | 1.33e-03 | 11 | 148 | 2 | C0393702 | |
| Disease | Brugada Syndrome 1 | 1.88e-03 | 13 | 148 | 2 | C4551804 | |
| Disease | Hereditary Motor and Sensory-Neuropathy Type II | 1.88e-03 | 13 | 148 | 2 | C0270914 | |
| Disease | Retinitis Pigmentosa | 1.89e-03 | 104 | 148 | 4 | C0035334 | |
| Disease | wet macular degeneration | 2.19e-03 | 14 | 148 | 2 | EFO_0004683 | |
| Disease | N-acetylglycine measurement | 2.19e-03 | 14 | 148 | 2 | EFO_0021002 | |
| Disease | autosomal dominant polycystic kidney disease (is_marker_for) | 2.19e-03 | 14 | 148 | 2 | DOID:898 (is_marker_for) | |
| Disease | Peripheral Nervous System Diseases | 2.54e-03 | 54 | 148 | 3 | C4721453 | |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 2.68e-03 | 55 | 148 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | neutrophil collagenase measurement | 2.86e-03 | 16 | 148 | 2 | EFO_0008248 | |
| Disease | Drug-induced agranulocytosis | 2.86e-03 | 16 | 148 | 2 | HP_0012235 | |
| Disease | Varicose veins | 2.95e-03 | 193 | 148 | 5 | HP_0002619 | |
| Disease | Age-related macular degeneration | 3.63e-03 | 18 | 148 | 2 | cv:C0242383 | |
| Disease | X-11470 measurement | 4.04e-03 | 19 | 148 | 2 | EFO_0021241 | |
| Disease | diet measurement, HOMA-B | 4.04e-03 | 19 | 148 | 2 | EFO_0004469, EFO_0008111 | |
| Disease | polycystic kidney disease (biomarker_via_orthology) | 4.04e-03 | 19 | 148 | 2 | DOID:0080322 (biomarker_via_orthology) | |
| Disease | Disorder of eye | 4.40e-03 | 212 | 148 | 5 | C0015397 | |
| Disease | memory performance | 4.70e-03 | 409 | 148 | 7 | EFO_0004874 | |
| Disease | schizophrenia (implicated_via_orthology) | 4.88e-03 | 68 | 148 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | cerebellar cortex volume measurement | 4.93e-03 | 21 | 148 | 2 | EFO_0010291 | |
| Disease | eye colour measurement | 4.95e-03 | 218 | 148 | 5 | EFO_0009764 | |
| Disease | testosterone measurement | CPPED1 SLC17A3 NAB1 TTC27 ZMIZ1 URB1 ATP6V0D1 ZFHX4 PGAP1 DUSP16 UGCG C2 PLCG1 USH2A | 5.00e-03 | 1275 | 148 | 14 | EFO_0004908 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QTAGYFLGNVLFLAL | 221 | O00400 | |
| VAGALFNINFYAGAL | 126 | P49682 | |
| GFLDYILGNSSDAQL | 376 | Q8NEM8 | |
| ILYSLVNGNDGAFEI | 281 | Q96JP9 | |
| NFTLDGYVQRFILNG | 276 | P78357 | |
| IGYIEDGAFSGQFNL | 96 | P0C7U0 | |
| LPEGIFDTNYNLFNL | 376 | P22792 | |
| RNALEIGFLVGQYFL | 206 | Q9UKL4 | |
| AEGANAAYLQLLNLF | 56 | Q9H9Q2 | |
| LYSILSNLGDFQFLF | 956 | Q9H7F0 | |
| NFNFLGQLLEYERSL | 286 | Q13202 | |
| IVATDLNEYGFLGLF | 1151 | Q8IUA7 | |
| ALNGDAFGVFVIYNI | 2571 | Q8WXG9 | |
| YLIFAENVFLGDQNS | 3466 | Q8WXG9 | |
| NFLADFYLVNGLVLE | 356 | Q8N6S4 | |
| QLYDGATALFLAAQG | 141 | Q8N6D5 | |
| QILADQYGNAISLFG | 361 | Q13085 | |
| LLFAYNGDVGLISIN | 236 | Q9NU02 | |
| DAIFQGLTQDQGFYT | 291 | Q12882 | |
| GLGEQLATENNLIFY | 671 | Q9BSW2 | |
| AGLLYDFQLINVEDF | 1171 | O60306 | |
| FELLQQITYLDGFDQ | 136 | Q9BTT0 | |
| DVFGDISFLQGNYEL | 51 | Q9UKI2 | |
| QQLFSYAILGFALSE | 111 | P48201 | |
| KLGQVFFLSNDLDLY | 391 | O94823 | |
| LLGQGYCVFLDNFNI | 321 | Q96DM1 | |
| FLNVLNFGDQGVYDI | 266 | Q96AA3 | |
| DTALQDYIEGGLINF | 431 | Q9NZL6 | |
| VDFSLSGRLLFAGYN | 331 | O14775 | |
| QLLDFLSGKQYAVGD | 131 | Q9NWS1 | |
| GLLYLNDDFQGGDLF | 611 | Q8IVL6 | |
| LYALFQSAEAGIFVL | 366 | Q96EP9 | |
| GGSFRLLQEGQALEY | 46 | P00751 | |
| AVNLLGLLFYLIFGE | 391 | O00476 | |
| SNLGNAYIFLGEFET | 246 | P81274 | |
| FTLFLAYDTQLVLGN | 261 | Q969X1 | |
| GDQALLGGIFYFLNI | 106 | Q96JY0 | |
| YLLGNLAAADLFAGV | 66 | Q9HBW0 | |
| GQDAGYIFGLQSLID | 401 | Q9UHH9 | |
| GNVQDFLRVLFGFLY | 21 | Q8IVD9 | |
| GANQLLELFDLFRYF | 76 | Q86V88 | |
| FRNLSLEYLDLFGNT | 291 | Q96L50 | |
| LASLEKLYIGQDQGF | 371 | A6NIV6 | |
| ANLLSYFDAFIQQGG | 21 | Q13506 | |
| FVGTLQYLAPELFEN | 181 | O15111 | |
| NQGILEFYGDDIALL | 551 | P06681 | |
| GTNLYGAQTFFLCLE | 296 | O43451 | |
| ELQLEYLLGAFESLG | 1686 | Q5VYK3 | |
| ELQYFLRAGTGLAAF | 1066 | Q9NYQ8 | |
| GLFLQLYLNGTDVLF | 201 | Q8NGJ9 | |
| YFNVSLESGDLLVNG | 71 | Q9Y5G3 | |
| AGLEYGDQLLEFNGI | 1386 | Q8TDM6 | |
| AYIGFIQSLAQFLGA | 746 | P55160 | |
| LNAAQIFAIYQLGLG | 371 | P50851 | |
| GAFEGLSNLRYLNLA | 191 | Q9HCJ2 | |
| NLTIDGYFYSLILEG | 3211 | P98164 | |
| GIILLTFGFILDQNY | 131 | Q9H3V2 | |
| IFIYNLGQDADEGIL | 246 | Q15717 | |
| LLYSFRLFGIQGEAQ | 6 | P0DTE2 | |
| GLFVAGINLTENLQY | 246 | Q9NUJ7 | |
| TLLYFDSVLLAFGNL | 26 | Q6ZVE7 | |
| QAGFSLDFYKNGDLI | 201 | P53708 | |
| GFLLLAGTQDGNIYQ | 291 | Q9BRP4 | |
| IFNAGELTLVEYGNN | 411 | Q9UG01 | |
| DGESYLQLQDLLDGF | 241 | P23677 | |
| AYFLLAAFALQADLG | 151 | Q96NE9 | |
| LYSLYGISQNAGDFL | 561 | Q15067 | |
| DLDGNGLLSLEEYNF | 416 | A8K855 | |
| GQDILVFYVNFGDLL | 886 | Q03188 | |
| IQAYLDNVFDVGGLL | 371 | Q8IVF7 | |
| ISPNFNFLGQLLDYE | 281 | Q9BY84 | |
| LNLEDGFLDFYSINR | 706 | Q8TDW7 | |
| GDQISFADYNLLDLL | 146 | P09211 | |
| DQAGGLIAFAQYIAE | 221 | Q16739 | |
| GGVLFLVLNSQFYEN | 156 | Q9BRF8 | |
| GLLLGGYNEFLEHAQ | 76 | Q5I0G3 | |
| SGQLTLYEFRQFFGL | 31 | P43080 | |
| TFLENLLRYGLFLGA | 16 | Q9NQG1 | |
| FGQSLELDGIIYLQA | 166 | P27707 | |
| INLLYGFFFASLQDD | 181 | Q92674 | |
| DYLFSQGLQGLKLFI | 721 | Q92674 | |
| GDFGLDVYLTQLIFG | 356 | Q9Y226 | |
| SNGDIYLLENGLNLF | 976 | P53992 | |
| IVGNFLENYGEALAA | 796 | Q9UHW9 | |
| NLGLLDFGAAYLFVI | 571 | Q16348 | |
| FYGITSNLVLFLNGA | 51 | Q8N697 | |
| LYAQGLLAIQFLEFF | 116 | O60779 | |
| LLFNGCILFGIEFSY | 121 | Q9Y2W3 | |
| LGDGALFYFGLNIET | 606 | Q16531 | |
| LFYFGLNIETGLLSD | 611 | Q16531 | |
| AAFEGLVNLRYLNLG | 201 | Q9NT99 | |
| LLAAIQLFGANLDDY | 1096 | P42345 | |
| LGALGIANSFLDEYL | 121 | Q99735 | |
| LDYDFQSGQLLVGIL | 116 | O00445 | |
| NIFSDGFLEYSGLNR | 4101 | O75445 | |
| LAFNLEGYIFVFLND | 166 | Q76EJ3 | |
| GYLFGENSDLNFLGN | 51 | Q96PX1 | |
| LDAATQIFFSYGLGL | 286 | P30531 | |
| EQDNDFLIYLVSFLG | 531 | Q7L1I2 | |
| LLEVAFFLYNGVSLG | 171 | P58872 | |
| VNLGGNEYLNLFLLG | 381 | Q86VW1 | |
| FNLQALGTYFEGLLE | 841 | P29590 | |
| QFYDLLNIFELNGLP | 246 | P53041 | |
| NLGLNAKGAILYAFE | 86 | Q16819 | |
| ESLNYALGAGDLFNV | 76 | Q99460 | |
| LYALNGVAFELDLQQ | 151 | Q6ZNE9 | |
| NFDNVGAGYLALLQV | 1401 | Q14524 | |
| KVNFDNVGLGYLSLL | 1386 | Q15858 | |
| YNIFLLLEVGTFNAL | 171 | Q5VSL9 | |
| GASEFLPIYLENQFI | 401 | Q86UG4 | |
| NYFGAESLFNKLVEL | 796 | Q93073 | |
| VNFNEELVALYGGSL | 126 | Q75T13 | |
| FLQLGDYGSAIQFLV | 961 | Q8NEZ3 | |
| LAFDLEGYAFILIND | 181 | Q9NTN3 | |
| GYLFALLLDGDFTLA | 221 | Q5PT55 | |
| GYFITQDSAFGNLIL | 81 | Q9NRY2 | |
| QAYVQFALSFLIAGD | 196 | O60287 | |
| AYLLGLLNSAGNEFT | 251 | Q9Y615 | |
| ALGLFIYQSLDAIDG | 101 | Q8WUD6 | |
| RSDLLLEGFNNYTFL | 296 | P35749 | |
| EGLLNTYQELLGLSF | 391 | Q9BYT8 | |
| GVLYNQFLSQVDFEL | 406 | Q92759 | |
| GDFYLQLIEGLDILF | 691 | Q9BXT8 | |
| LGNVDAFQLADGLQY | 566 | Q6P2Q9 | |
| QLENGYTLFDYDVGL | 51 | Q96PU4 | |
| ALLENFGFELVIQYN | 1866 | Q86UP3 | |
| GALFLFLSANALGNY | 51 | Q8N966 | |
| LLAGALTELGYNVFF | 116 | Q9H2L4 | |
| FLLAFLSYNRSLDQG | 176 | Q8IUR5 | |
| QYGFALEDFKQAALI | 191 | Q86TZ1 | |
| LGTLENGNLDLYFVD | 376 | Q9Y2W6 | |
| FLGLDDLEYLQADFN | 126 | Q96PX8 | |
| ATQLFNLLSGEGYLE | 221 | Q7Z404 | |
| FLLIEDQGAQGYELF | 471 | P15498 | |
| LPEFQQFLLDYQGEL | 251 | P19174 | |
| ILSLGDNFYFTGVQD | 66 | P13686 | |
| FDNVGAGYLALLQVA | 1396 | Q9UQD0 | |
| YAQLGFLVFGSQVDD | 421 | Q9NZM6 | |
| LGADESLLNRLYGFL | 96 | Q9UPN7 | |
| AAGYFQNLFLNTGLD | 51 | O15060 | |
| LASFGNDDILNLARY | 961 | O60290 | |
| QIQNDYLFQLGFGEL | 491 | O60346 | |
| FLGGLDALYSLRLDQ | 71 | Q9NS98 | |
| DFGDLLIYSGALLVF | 66 | C9JI98 | |
| QSLGQGLEFLIYFQG | 56 | A0A1B0GXF2 | |
| FENYTGVQILLYGDL | 66 | Q9NUQ2 | |
| SGSFLQLLLEGNYEA | 31 | Q6P3X3 | |
| FLANLLGASVQEYFV | 666 | Q92547 | |
| KYFLNLINGAFLVLG | 11 | P0C672 | |
| ANGLLDFDIFYNVTG | 546 | Q99959 | |
| NSLFIDGSFQLLYFI | 541 | Q9HBA0 | |
| QQGFDLDLGYRLLAV | 66 | Q9ULJ6 | |
| FGKYNFLLQEDGDLA | 946 | Q9UGR2 | |
| ELYFNVDNGYLEGLV | 6 | P61421 | |
| FQNYFADGVLSLGEL | 61 | Q96P71 |